SCHEMBL6097207

SCHEMBL6097207

Cc1cccc2c(C3=C(Cl)C(=O)C=C(Cl)C3=O)c[nH]c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 9/20 0.44
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
BRPF1 P55201 1/20 0.40
NR4A2 P43354 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCA P17252 1/20 0.38
PRKCH P24723 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCD Q05655 1/20 0.38
ATP4A P20648 1/20 0.37
ATP4B P51164 1/20 0.37
HTR2A P28223 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SOS2 Q07890 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6097786 0.86 DYRK1A (0.43) ARNR4A2PRKCBPRKCAPRKCH
SCHEMBL6094232 0.86 AR (0.34) ARPRKCBPRKCAPRKCHPRKCE
SCHEMBL6099160 0.84 CSNK2A2 (0.34)
SCHEMBL6096052 0.84 GPR84 (0.40) AR
SCHEMBL6096554 0.84 DYRK1A (0.41) AR
SCHEMBL6095726 0.84 ALDH1A1 (0.44) ARHTR2AKDM4EMAPTSMN1; SMN2
SCHEMBL6096077 0.84 AR (0.35) ARPRKCBPRKCAPRKCHPRKCE
SCHEMBL6094634 0.82 PARP1 (0.40) ARPRKCBPRKCAPRKCHPRKCE
SCHEMBL6097186 0.82 MEN1 (0.37) ARHTR2AALDH1A1TSHRHTT
SCHEMBL6095205 0.82 CSNK2A2 (0.41) ARPRKCBPRKCAPRKCHPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA AR 4343/4885TRIM24 1113/4885TRIM33 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.